Temperature Management Market Size

Temperature Management Market Analysis

The Temperature Management Market size is estimated at USD 3.21 billion in 2024, and is expected to reach USD 3.87 billion by 2029, growing at a CAGR of 3.88% during the forecast period (2024-2029).

The outbreak of the COVID-19 pandemic impacted the temperature management market. During the initial phase of the pandemic, many surgical procedures were canceled or postponed, which reduced the demand for temperature management systems as it is one of the essential requirements of post-surgery. For instance, according to the NCBI research study published in 2021, a large number of surgical procedures were canceled or postponed during COVID-19 for an indefinite period. Thus, such a scenario imposed a slight adverse impact on the market during the initial phase of the pandemic. However, many healthcare organizations across the globe published recommendations or guidelines emphasizing the importance of maintaining a normothermia environment to avoid COVID-19 contamination. For instance, as per the research article published by 3M in 2021, AORN (Association of periOperative Registered Nurses) has recommended using forced air warmers during surgical procedures in COVID-19-positive patients to decrease the risk of hypothermia. Therefore, owing to such guidelines and with the resumption of surgical procedures, the market started to gain traction and is expected to continue the upward trend over the forecast period.

The increasing prevalence of cancer, infectious diseases, and cardiovascular diseases, the rising number of surgical procedures, and the development of technologically advanced intravascular systems are the major drivers for the market. For instance, according to the WHO 2022, the WHO GISRS laboratories tested more than 317198 specimens from December 2021 to January 2022. 16862 people were positive for influenza viruses, of which 10744 (63.7%) were typed as influenza A and 6118 (36.3%) as influenza B. Of the sub-typed influenzaA viruses, 224 (4.3%) were influenza A(H1N1) pdm09, and 4930 (95.7%) were influenza A(H3N2). Similarly, according to the report published by the European CDC in March 2021, it was reported that every year around 500,000 sexually transmitted infections detected in the European Union, European Economic Area (EEA), and the United Kingdom. Furthermore, according to the GLOBOCAN Report 2020, globally, around 19,292,789 new cancer cases have been reported, and 9,958,133 reported cancer deaths. The majorly affecting cancers are breast cancer, lung cancer, colorectum cancer, and prostate cancer. Hyperthermia is an essential treatment for cancer and infectious diseases, which can be attained by using temperature management systems. Therefore, increasing cases of cancer and infectious diseases across the globe is anticipated to propel market growth over the forecast period.

The increasing number of surgical procedures and product launches by the key players are also surging the market growth. For instance, according to the report published by the Department of Health & Family Welfare and Ministry of Health & Family Welfare in 2021-2022, till September 2021, about 8.29 lakh people visited OPDs, and around 33,830 surgeries were performed in Safdarjung Hospital, India. The same source also reported that around 25,101 minor surgeries were performed, and about 9,327 major surgeries were performed in India for the year 2020-21. Maintaining normal body temperature provides valuable benefits to surgical patients, including risk reduction of surgical site infection, reduced mortality, fewer post-operative cardiac events, reduced blood loss, faster recovery times, and shorter patient hospitalizations. Temperature management systems offer hospitals and clinicians with a safe and effective method of keeping patients warm before, during, and after surgery. Since temperature management systems are one of the essential requirements, thus increasing the number of surgical procedures is expected to boost the market growth.

Furthermore, the launch of new product lines by the key players are also anticipated to create new opportunities in the market. For instance, in April 2021, Danish medtech company MEQU launched an in-hospital solution, M Station, for its blood and IV fluid warming device, M Warmer System. M Warmer System is a portable blood and IV fluid warming device that is adopted in the pre-hospital and military sectors. Using a patented warming technology, the M Warmer is able to warm infusion fluids from cold to body temperature in under 10 seconds. Thus, increasing product launches and a rising number of surgical procedures are anticipated to propel the market growth over the forecast period.

However, the high cost of temperature management systems and product recalls may restrain the market growth over the forecast period.